Literature DB >> 8533830

Missense mutation of the beta-cardiac myosin heavy-chain gene in hypertrophic cardiomyopathy.

S Arai1, R Matsuoka, K Hirayama, H Sakurai, M Tamura, T Ozawa, M Kimura, S Imamura, Y Furutani, K Joh-o.   

Abstract

Hypertrophic cardiomyopathy occurs as an autosomal dominant familial disorder or as a sporadic disease without familial involvement. We describe a missense mutation of the beta-cardiac myosin heavy chain (MHC) gene, a G to T transversion (741 Gly-->Trp) identified by direct sequencing of exon 20 in four individuals affected with familial hypertrophic cardiomyopathy. Three individuals with sporadic hypertrophic cardiomyopathy, whose parents are clinically and genetically unaffected, had sequence variations of exon 34 of the alpha-cardiac MHC gene (a C to T transversion, 1658 Asp-->Asp, resulting in FokI site polymorphism), of intron 33 of the alpha-cardiac MHC gene (a G to A and an A to T transversion), and also of intron 14 of the beta-cardiac MHC gene (a C to T transversion in a patient with Noonan syndrome). Including our case, 30 missense mutations of the beta-cardiac MHC gene in 49 families have been reported thus far worldwide. Almost all are located in the region of the gene coding for the globular head of the molecule, and only one mutation was found in both Caucasian and Japanese families. Missense mutations of the beta-cardiac MHC gene in hypertrophic cardiomyopathy may therefore differ according to race.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8533830     DOI: 10.1002/ajmg.1320580314

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

1.  Heterologous expression of wild-type and mutant beta-cardiac myosin changes the contractile kinetics of cultured mouse myotubes.

Authors:  Gaynor Miller; Joanne Maycock; Ed White; Michelle Peckham; Sarah Calaghan
Journal:  J Physiol       Date:  2003-02-07       Impact factor: 5.182

2.  Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy.

Authors:  Sinead L Murphy; Jason H Anderson; Jamie D Kapplinger; Teresa M Kruisselbrink; Bernard J Gersh; Steve R Ommen; Michael J Ackerman; J Martijn Bos
Journal:  J Cardiovasc Transl Res       Date:  2016-02-25       Impact factor: 4.132

3.  Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.

Authors:  Ayako Chida; Kei Inai; Hiroki Sato; Eriko Shimada; Tsutomu Nishizawa; Mitsuyo Shimada; Michiko Furutani; Yoshiyuki Furutani; Yoichi Kawamura; Masaya Sugimoto; Jun Ishihara; Masako Fujiwara; Takashi Soga; Masatoshi Kawana; Shinya Fuji; Shigeru Tateno; Kenji Kuraishi; Shigetoyo Kogaki; Mitsuhiro Nishimura; Mamoru Ayusawa; Fukiko Ichida; Hirokuni Yamazawa; Rumiko Matsuoka; Shigeaki Nonoyama; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2016-11-24       Impact factor: 2.037

4.  Identification of a novel hypertrophic cardiomyopathy-associated mutation using targeted next-generation sequencing.

Authors:  Yue Zhao; Yue Feng; Xiaoxue Ding; Shuwei Dong; Hong Zhang; Jiahuan Ding; Xueshan Xia
Journal:  Int J Mol Med       Date:  2017-05-11       Impact factor: 4.101

5.  Case Report: Identification of Mutations in LAMP2 in Two Chinese Infants With Danon Disease.

Authors:  Luyan Zhang; Fan Yang; Mei Chen; Ming Zhou; Tianwei Qian; Mohammed Omer Mujtaba; Abdul Haseeb Mohammed; Jie Yin; Xueying Cheng; Jinlong Chen; Yuming Qin; Shiwei Yang
Journal:  Front Genet       Date:  2021-01-11       Impact factor: 4.599

6.  Novel Mutations in β-MYH7 Gene in Indian Patients With Dilated Cardiomyopathy.

Authors:  Deepa Selvi Rani; Archana Vijaya Kumar; Pratibha Nallari; Katakam Sampathkumar; Perundurai S Dhandapany; Calambur Narasimhan; Andiappan Rathinavel; Kumarasamy Thangaraj
Journal:  CJC Open       Date:  2021-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.